The association between different regimens of glucocorticoid and antifungal treatment with the prognosis of allergic bronchopulmonary aspergillosis: a retrospective cohort study
Long-term GC increases risks of adverse outcomes in ABPA, while low-dose GC demonstrates protective effects. Voriconazole provides better initial response but inferior long-term lesion resolution compared to itraconazole. More non-relapse patients on combination therapy may related to possible benefit of combination therapy. Prospective studies are warranted to confirm these findings.
Authors
- huayin li
- L. CHEN
- Hongni Jiang (ORCID: https://orcid.org/0000-0002-6820-3723)
- Sijiao Wang
- Yiding Xu
- Minghui Wang (ORCID: https://orcid.org/0000-0003-4517-6782)
- Xiaohua Zhang
- Qin Wang
- Xiaodan Zhu
Institutions
- Shandong University (CN)
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Fuyang Second People's Hospital (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1080/07853890.2025.2612394
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00